Dr. Moussa Antoine Chalah graduated from the American University of Beirut (AUB, Class 2010) with a BS in Biological Sciences and a minor in literature. He then completed his medical education (MD) at the Gilbert & Rosy Marie Chagoury School of Medicine at Lebanese American University (LAU, class 2014). His passion for clinical research as a power for change and improvement in the health care field pushed him to pursue his graduate studies (MSc) in neurosciences at University Paris Est- Creteil (UPEC), France (2014-2016). Throughout this period, he worked as a medical researcher with the neurophysiology and cortical excitability team at Henri Mondor Hospital, France. His research was focused on the use of Non-Invasive Brain Stimulation techniques (NIBS) in treating various neuropsychiatric symptoms. In the last few years, these techniques –namely the non-invasive application of electric and magnetic fields at different brain sites- have gained attention in the field of neurorehabilitation. In this perspective, he is particularly interested in studying the effects of NIBS techniques on pain, attention, mood, and fatigue in patients with multiple sclerosis (MS). During his time at UPEC, Chalah had the chance to attend many national and European congresses, where he presented abstracts and gave lectures, covering the use of NIBS in the treatment of pain syndromes, attention, fatigue, cognition and mood. Since 2014, he is member of the Board of the French Society of Neurophysiology and the French Network of Multiple Sclerosis. PhD candidate, reviewer of different International Scientific Journals and author of many papers published in PubMed indexed International Journals with Impact Factor.
Dr. Moussa Antoine Chalah's research focusses on various aspects of multiple sclerosis research, including the study of brain plasticity, psychiatric manifestations, cognitive functions, as well as the application of NIBS techniques (transcranial direct current stimulation and transcranial magnetic stimulation) as promising tools to modulate neuropsychiatric symptoms.